A2 Milk Seeks Profit Growth with New Manufacturing Purchase

Strategic Moves to Boost Profitability

A2 Milk, a leading player in the infant formula market, has taken significant steps to enhance its profitability and expand its operations. The company is focusing on increasing its presence in the Chinese market, which remains a critical growth area. By acquiring a manufacturing plant in New Zealand’s North Island, A2 Milk aims to strengthen its supply chain and meet the rising demand for infant formula.

The company recently provided an outlook for its earnings before interest, tax, depreciation, and amortization (EBITDA) margin for the 12 months ending June 2026. It expects this margin to be between 15% and 16%, which would represent an improvement over the 14.4% EBITDA margin recorded in fiscal 2025. This positive outlook suggests that A2 Milk is on track to achieve stronger profit margins in the coming years.

In addition to improving its EBITDA margin, A2 Milk anticipates revenue growth from continuing operations of a high single-digit percentage in the current 12-month period. This projection underscores the company's confidence in its ability to maintain steady growth despite market challenges.

Supply Chain Overhaul and Acquisition

To support its strategic goals, A2 Milk has undertaken a major overhaul of its supply chain. Central to this effort is the acquisition of an integrated nutritional manufacturing facility in Pokeno, valued at approximately 282 million New Zealand dollars (US$167.1 million). The facility was purchased from a unit of China Mengniu Dairy, one of the largest dairy companies in China.

A2 Milk plans to invest an additional NZ$100 million to increase production capacity at the Pokeno site. The company also intends to hire more than 100 additional employees over time, further solidifying its operational footprint in New Zealand.

“The acquisition of the Pokeno manufacturing facility and related products represents a pivotal moment for The a2 Milk Co. and the execution of our supply chain transformation strategy,” said David Bortolussi, Chief Executive of A2 Milk.

This move is particularly significant because it brings two product registrations for the China-label infant formula market, which is a key target for A2 Milk’s expansion efforts.

Divestment and Financial Strategy

Alongside the acquisition, A2 Milk announced the sale of its interests in the Mataura Valley Milk (MVM) business to Open Country Dairy. While the company expects to generate net proceeds of around NZ$100 million from this deal, it will also recognize a loss on the sale of approximately NZ$130 million. Despite this loss, the transaction is expected to provide financial flexibility for the company.

A2 Milk has signaled that these deals will lead to a one-off return for shareholders. The board has expressed its intention to declare a fully franked and unimputed special dividend of NZ$300 million, pending regulatory approval and the completion of the MVM divestment.

Strong Financial Performance

In fiscal 2025, A2 Milk reported a net profit of NZ$202.9 million, up from NZ$167.6 million in the previous year. Annual revenue reached NZ$1.90 billion, reflecting a 14% increase. This growth was in line with the company’s guidance for low to mid-double digit percent growth, which was shared with investors in February.

The company declared a final dividend of 11.5 New Zealand cents per share. A2 Milk maintains a policy of paying out 60-80% of net profit as dividends once one-off items are excluded.

Market Expansion in China

Despite challenges posed by a declining population in China, A2 Milk has managed to expand its market share in the infant formula sector. In fiscal 2025, infant milk formula sales rose by 10% overall, with English label sales growing by 17%. This growth highlights the company’s ability to adapt and thrive in a competitive market.

China’s fertility rate, which is currently around one, remains one of the lowest globally. However, recent government initiatives aim to boost the birth rate. Beijing has introduced a basic national subsidy of 3,600 yuan (about US$500) per child annually until the age of three, as outlined in a central government decree.

These developments signal a potential shift in the market dynamics, offering new opportunities for A2 Milk and other players in the infant formula industry.